SZSE:300254 (China)
Â
Class A
Â¥
7.97
(+2.05%)
Jul 5
Business Description
Shanxi C&Y Pharmaceutical Group Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE1000016D0
Share Class Description:
SZSE:300254: Class ACompare
Compare
Traded in other countries / regions
300254.China IPO Date
2011-08-19Description
Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | 4.06 | |||||
| Interest Coverage | 1.83 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.22 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.9 | |||||
| 3-Year EPS without NRI Growth Rate | 61.2 | |||||
| 3-Year Book Growth Rate | -6.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.84 | |||||
| 9-Day RSI | 43.99 | |||||
| 14-Day RSI | 44 | |||||
| 6-1 Month Momentum % | -11.69 | |||||
| 12-1 Month Momentum % | 8.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | |||||
| Quick Ratio | 0.65 | |||||
| Cash Ratio | 0.29 | |||||
| Days Inventory | 171.27 | |||||
| Days Sales Outstanding | 42.07 | |||||
| Days Payable | 61.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | 2.55 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.64 | |||||
| Operating Margin % | 5.86 | |||||
| Net Margin % | 5.67 | |||||
| FCF Margin % | 0.59 | |||||
| ROE % | 7.86 | |||||
| ROA % | 2.96 | |||||
| ROIC % | 3.27 | |||||
| ROC (Joel Greenblatt) % | 29.13 | |||||
| ROCE % | 10.06 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.17 | |||||
| PE Ratio without NRI | 60.38 | |||||
| Price-to-Owner-Earnings | 173.26 | |||||
| PS Ratio | 2.39 | |||||
| PB Ratio | 3.11 | |||||
| Price-to-Tangible-Book | 20.13 | |||||
| Price-to-Free-Cash-Flow | 398.5 | |||||
| Price-to-Operating-Cash-Flow | 24.08 | |||||
| EV-to-EBIT | 21.63 | |||||
| EV-to-EBITDA | 21.63 | |||||
| EV-to-Revenue | 2.74 | |||||
| EV-to-FCF | 462.45 | |||||
| Price-to-Projected-FCF | 2.92 | |||||
| Price-to-Median-PS-Value | 1.14 | |||||
| Price-to-Graham-Number | 7.38 | |||||
| Earnings Yield (Greenblatt) % | 4.62 | |||||
| FCF Yield % | 0.25 | |||||
| Forward Rate of Return (Yacktman) % | -16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanxi C&Y Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 805.613 | ||
| EPS (TTM) (Â¥) | 0.189 | ||
| Beta | 1.23 | ||
| Volatility % | 45.78 | ||
| 14-Day RSI | 44 | ||
| 14-Day ATR (Â¥) | 0.41799 | ||
| 20-Day SMA (Â¥) | 8.167 | ||
| 12-1 Month Momentum % | 8.6 | ||
| 52-Week Range (Â¥) | 4.98 - 11.86 | ||
| Shares Outstanding (Mil) | 241.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanxi C&Y Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanxi C&Y Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanxi C&Y Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254)'s stock price today?
The current price of SZSE:300254 is ¥7.97. The 52 week high of SZSE:300254 is ¥11.86 and 52 week low is ¥4.98.
When is next earnings date of Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254)?
The next earnings date of Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254) is .
Does Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254) pay dividends? If so, how much?
Shanxi C&Y Pharmaceutical Group Co Ltd(SZSE:300254) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers